a Natural science Laboratory, Division of Medicinal and Pharmaceutical Chemistry, Department of Pharmaceutical Technology, P.O. Box 17020 , Jadavpur University , Kolkata 700032 , West Bengal , India.
b Laboratory of Drug Design and Discovery, Department of Pharmaceutical Sciences , Dr Hari Singh Gour University , Sagar 470003 , Madhya Pradesh , India.
SAR QSAR Environ Res. 2018 May;29(5):385-408. doi: 10.1080/1062936X.2018.1447511. Epub 2018 Mar 23.
The current study deals with chemometric modelling strategies (Naïve Bayes classification, hologram-based quantitative structure-activity relationship (HQSAR), comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA)) to explore the important features of hydroxylamine derivatives for exerting potent human immunodeficiency virus-1 (HIV-1) protease inhibition. Depending on the statistically validated reliable and robust quantitative structure-activity relationship (QSAR) models, important and crucial structural features have been identified that may be responsible for enhancing the activity profile of these hydroxylamine compounds. Arylsulfonamide function along with methoxy or fluoro substitution is important for enhancing activity. Bulky steric substitution at the sulfonamide nitrogen disfavours activity whereas smaller hydrophobic substitution at the same position is found to be favourable. Apart from the crucial oxazolidinone moiety, pyrrolidine, cyclic urea and methyl ester functions are also responsible for increasing the HIV-1 protease inhibitory profile. Observations derived from these modelling studies may be utilized further in designing promising HIV-1 protease inhibitors of this class.
本研究运用化学计量学建模策略(朴素贝叶斯分类、基于全息图的定量构效关系(HQSAR)、比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)),探讨羟胺衍生物发挥强效人类免疫缺陷病毒-1(HIV-1)蛋白酶抑制作用的重要特征。基于经统计学验证的可靠且稳健的定量构效关系(QSAR)模型,确定了重要的结构特征,这些特征可能有助于增强这些羟胺化合物的活性。芳基磺酰胺功能以及甲氧基或氟取代对于提高活性很重要。磺酰胺氮上的大位阻取代不利于活性,而同一位置的较小疏水性取代则有利于活性。除了关键的恶唑烷酮部分外,吡咯烷、环状脲和甲酯功能也有助于提高 HIV-1 蛋白酶抑制谱。这些建模研究得出的观察结果可进一步用于设计此类具有前景的 HIV-1 蛋白酶抑制剂。